Kathleen Stergiopoulos Joseph J Brennan Robin Mathews John F Setaro Smadar Kort
10.2147/vhrm.s4261
Vasc Health Risk Manag
2008;4(6):1475-80.
acute myocardial infarction anabolic steroid use polycythemia
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/19337562/
Anabolic Agents / adverse effects Coronary Artery Disease / chemically induced Myocardial Infarction / chemically induced Polycythemia / chemically induced Testosterone / adverse effects Weight Lifting
Anabolic Agents / adverse effects Coronary Artery Disease / chemically induced Myocardial Infarction / chemically induced Polycythemia / chemically induced Testosterone / adverse effects Weight Lifting Case Reports Review Adult Anabolic Agents / administration & dosage Angioplasty, Balloon, Coronary / instrumentation Blood Viscosity / drug effects Combined Modality Therapy Coronary Angiography Coronary Artery Disease / blood Coronary Artery Disease / therapy Electrocardiography Humans Injections, Intramuscular Male Myocardial Infarction / blood Myocardial Infarction / therapy Phlebotomy Platelet Aggregation Inhibitors / therapeutic use Polycythemia / blood Polycythemia / therapy Risk Factors Stents Testosterone / administration & dosage Treatment Outcome Anabolic Agents Platelet Aggregation Inhibitors Testosterone
PMC2663437
19337562
Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature
2008